MURPHY ANDREW J 4
4 · REGENERON PHARMACEUTICALS, INC. · Filed Aug 15, 2024
Insider Transaction Report
Form 4
MURPHY ANDREW J
EVP Research
Transactions
- Sale
Common Stock
2024-08-14$1148.52/sh−537$616,755→ 53,706 total - Sale
Common Stock
2024-08-14$1153.74/sh−987$1,138,741→ 51,199 total - Sale
Common Stock
2024-08-14$1142.94/sh−48$54,861→ 54,566 total - Exercise/Conversion
Common Stock
2024-08-13$399.66/sh+20,000$7,993,200→ 68,306 total - Sale
Common Stock
2024-08-14$1140.31/sh−55$62,717→ 54,614 total - Sale
Common Stock
2024-08-14$1156.43/sh−1,016$1,174,933→ 49,004 total - Sale
Common Stock
2024-08-14$1143.28/sh−79$90,319→ 54,487 total - Sale
Common Stock
2024-08-14$1146.60/sh−51$58,477→ 54,243 total - Sale
Common Stock
2024-08-14$1149.60/sh−294$337,982→ 53,412 total - Sale
Common Stock
2024-08-14$1150.41/sh−844$970,946→ 52,568 total - Sale
Common Stock
2024-08-14$1152.36/sh−197$227,015→ 52,186 total - Sale
Common Stock
2024-08-14$1154.66/sh−777$897,171→ 50,422 total - Sale
Common Stock
2024-08-14$1155.76/sh−402$464,616→ 50,020 total - Sale
Common Stock
2024-08-14$1158.78/sh−189$219,009→ 48,637 total - Sale
Common Stock
2024-08-14$1157.41/sh−178$206,019→ 48,826 total - Sale
Common Stock
2024-08-14$1159.69/sh−331$383,857→ 48,306 total - Tax Payment
Common Stock
2024-08-13$1141.49/sh−13,637$15,566,499→ 54,669 total - Sale
Common Stock
2024-08-14$1144.89/sh−45$51,520→ 54,442 total - Sale
Common Stock
2024-08-14$1145.58/sh−148$169,546→ 54,294 total - Sale
Common Stock
2024-08-14$1151.46/sh−185$213,020→ 52,383 total - Exercise/Conversion
Non-Qualified Stock Option (right to buy)
2024-08-13−20,000→ 0 totalExercise: $399.66Exp: 2024-12-16→ Common Stock (20,000 underlying)
Holdings
- 4,326(indirect: By 401(k))
Common Stock
Footnotes (15)
- [F1]Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c) adopted on May 9, 2023.
- [F10]Represents volume-weighted average price of sales of 402 shares of Company stock on August 14, 2024 at prices ranging from $1,155.04 to $1,155.98. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 14, 2024 at each separate price.
- [F11]Represents volume-weighted average price of sales of 1,016 shares of Company stock on August 14, 2024 at prices ranging from $1,156.06 to $1,156.93. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 14, 2024 at each separate price.
- [F12]Represents volume-weighted average price of sales of 178 shares of Company stock on August 14, 2024 at prices ranging from $1,157.13 to $1,157.87. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 14, 2024 at each separate price.
- [F13]Represents volume-weighted average price of sales of 189 shares of Company stock on August 14, 2024 at prices ranging from $1,158.53 to $1,158.87. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 14, 2024 at each separate price.
- [F14]Represents volume-weighted average price of sales of 331 shares of Company stock on August 14, 2024 at prices ranging from $1,159.21 to $1,159.97. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 14, 2024 at each separate price.
- [F15]The stock option award vests in four equal annual installments, commencing one year after the date of grant.
- [F2]Represents volume-weighted average price of sales of 148 shares of Company stock on August 14, 2024 at prices ranging from $1,145.33 to $1,145.98. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 14, 2024 at each separate price.
- [F3]Represents volume-weighted average price of sales of 537 shares of Company stock on August 14, 2024 at prices ranging from $1,148.06 to $1,148.98. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 14, 2024 at each separate price.
- [F4]Represents volume-weighted average price of sales of 294 shares of Company stock on August 14, 2024 at prices ranging from $1,149.13 to $1,149.93. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 14, 2024 at each separate price.
- [F5]Represents volume-weighted average price of sales of 844 shares of Company stock on August 14, 2024 at prices ranging from $1,150.10 to $1,150.92. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 14, 2024 at each separate price.
- [F6]Represents volume-weighted average price of sales of 185 shares of Company stock on August 14, 2024 at prices ranging from $1,151.09 to $1,151.49. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 14, 2024 at each separate price.
- [F7]Represents volume-weighted average price of sales of 197 shares of Company stock on August 14, 2024 at prices ranging from $1,152.27 to $1,152.60. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 14, 2024 at each separate price.
- [F8]Represents volume-weighted average price of sales of 987 shares of Company stock on August 14, 2024 at prices ranging from $1,153.07 to $1,153.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 14, 2024 at each separate price.
- [F9]Represents volume-weighted average price of sales of 777 shares of Company stock on August 14, 2024 at prices ranging from $1,154.05 to $1,154.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 14, 2024 at each separate price.